For Subcutaneous use (s.c.)
The recommended dose is 2 mg robenacoxib/kg body weight (1 mL of the veterinary medicinal product per 10 kg body weight).
Administer the veterinary medicinal product approximately 30 minutes before the start of surgery, for example around the time of induction of general anaesthesia.
After surgery in cats, once daily treatment may be continued at the same dosage and at the same time every day for up to 2 days.
After soft tissue surgery in dogs, once daily treatment may be continued at the same dosage and at the same time every day for up to 2 days.
The interchangeable use of the veterinary medicinal products containing robenacoxib in the form of tablets and solution for injection has been tested in target animal safety studies and was shown to be well tolerated by cats and dogs.
The veterinary medicinal products containing robenacoxib in the form of solution for injection or tablets may be used interchangeably in accordance with the indications and directions of use approved for each pharmaceutical form. Treatment should not exceed one dose (either tablet or injection) per day. Please note that the recommended doses for the two formulations may be different.
The stopper should be subjected to a maximum of 16 piercings.
Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
The safety of the veterinary medicinal product has not been established in cats and dogs used for breeding.
Pregnancy and lactation:
Do not use in pregnant and lactating animals.
Fertility:
Do not use in breeding animals.